$3062 | SAVE $418 | Single User
$5262 | SAVE $718 | Site License
$5262 | SAVE $718 | Global License

H1N1 Vaccines-EMEA Market Status and Trend Report 2013-2023
[Published by MIReports]

Published by MIReports: 17 Nov 2019 | 238162 | In Stock
Related Topics: AstraZeneca , GlaxoSmithKline , Novartis , Protein , Vaccine

Introduction

Report Summary

H1N1 Vaccines-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on H1N1 Vaccines industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole EMEA and Regional Market Size of H1N1 Vaccines 2013-2017, and development forecast 2018-2023

Main market players of H1N1 Vaccines in EMEA, with company and product introduction, position in the H1N1 Vaccines market

Market status and development trend of H1N1 Vaccines by types and applications

Cost and profit status of H1N1 Vaccines, and marketing status

Market growth drivers and challenges

The report segments the EMEA H1N1 Vaccines market as:

EMEA H1N1 Vaccines Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

Europe

Middle East

Africa

EMEA H1N1 Vaccines Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Inactivated vaccines

Type II

EMEA H1N1 Vaccines Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

Swine flu

Application 2

EMEA H1N1 Vaccines Market: Players Segment Analysis (Company and Product introduction, H1N1 Vaccines Sales Volume, Revenue, Price and Gross Margin):

Medimmune

AstraZeneca

Novartis

GlaxoSmithKline

Serum Institute

Sinovac Biotech

Zydus Cadila

BioCSL

Mitsubishi Tanabe Pharma

Protein Sciences Corporation

Baxter International

Sanofi Pastuer

Commonwealth Serum Laboratories (CSL)

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of Contents
for H1N1 Vaccines-EMEA Market Status and Trend Report 2013-2023 [Published by MIReports]

  • Table of Contents

    Chapter 1 Overview of H1N1 Vaccines

    1.1 Definition of H1N1 Vaccines in This Report

    1.2 Commercial Types of H1N1 Vaccines

    1.2.1 Inactivated vaccines

    1.2.2 Type II

    1.3 Downstream Application of H1N1 Vaccines

    1.3.1 Swine flu

    1.3.2 Application 2

    1.4 Development History of H1N1 Vaccines

    1.5 Market Status and Trend of H1N1 Vaccines 2013-2023

    1.5.1 EMEA H1N1 Vaccines Market Status and Trend 2013-2023

    1.5.2 Regional H1N1 Vaccines Market Status and Trend 2013-2023

    Chapter 2 EMEA Market Status and Forecast by Regions

    2.1 Market Status of H1N1 Vaccines in EMEA 2013-2017

    2.2 Consumption Market of H1N1 Vaccines in EMEA by Regions

    2.2.1 Consumption Volume of H1N1 Vaccines in EMEA by Regions

    2.2.2 Revenue of H1N1 Vaccines in EMEA by Regions

    2.3 Market Analysis of H1N1 Vaccines in EMEA by Regions

    2.3.1 Market Analysis of H1N1 Vaccines in Europe 2013-2017

    2.3.2 Market Analysis of H1N1 Vaccines in Middle East 2013-2017

    2.3.3 Market Analysis of H1N1 Vaccines in Africa 2013-2017

    2.4 Market Development Forecast of H1N1 Vaccines in EMEA 2018-2023

    2.4.1 Market Development Forecast of H1N1 Vaccines in EMEA 2018-2023

    2.4.2 Market Development Forecast of H1N1 Vaccines by Regions 2018-2023

    Chapter 3 EMEA Market Status and Forecast by Types

    3.1 Whole EMEA Market Status by Types

    3.1.1 Consumption Volume of H1N1 Vaccines in EMEA by Types

    3.1.2 Revenue of H1N1 Vaccines in EMEA by Types

    3.2 EMEA Market Status by Types in Major Countries

    3.2.1 Market Status by Types in Europe

    3.2.2 Market Status by Types in Middle East

    3.2.3 Market Status by Types in Africa

    3.3 Market Forecast of H1N1 Vaccines in EMEA by Types

    Chapter 4 EMEA Market Status and Forecast by Downstream Industry

    4.1 Demand Volume of H1N1 Vaccines in EMEA by Downstream Industry

    4.2 Demand Volume of H1N1 Vaccines by Downstream Industry in Major Countries

    4.2.1 Demand Volume of H1N1 Vaccines by Downstream Industry in Europe

    4.2.2 Demand Volume of H1N1 Vaccines by Downstream Industry in Middle East

    4.2.3 Demand Volume of H1N1 Vaccines by Downstream Industry in Africa

    4.3 Market Forecast of H1N1 Vaccines in EMEA by Downstream Industry

    Chapter 5 Market Driving Factor Analysis of H1N1 Vaccines

    5.1 EMEA Economy Situation and Trend Overview

    5.2 H1N1 Vaccines Downstream Industry Situation and Trend Overview

    Chapter 6 H1N1 Vaccines Market Competition Status by Major Players in EMEA

    6.1 Sales Volume of H1N1 Vaccines in EMEA by Major Players

    6.2 Revenue of H1N1 Vaccines in EMEA by Major Players

    6.3 Basic Information of H1N1 Vaccines by Major Players

    6.3.1 Headquarters Location and Established Time of H1N1 Vaccines Major Players

    6.3.2 Employees and Revenue Level of H1N1 Vaccines Major Players

    6.4 Market Competition News and Trend

    6.4.1 Merger, Consolidation or Acquisition News

    6.4.2 Investment or Disinvestment News

    6.4.3 New Product Development and Launch

    Chapter 7 H1N1 Vaccines Major Manufacturers Introduction and Market Data

    7.1 Medimmune

    7.1.1 Company profile

    7.1.2 Representative H1N1 Vaccines Product

    7.1.3 H1N1 Vaccines Sales, Revenue, Price and Gross Margin of Medimmune

    7.2 AstraZeneca

    7.2.1 Company profile

    7.2.2 Representative H1N1 Vaccines Product

    7.2.3 H1N1 Vaccines Sales, Revenue, Price and Gross Margin of AstraZeneca

    7.3 Novartis

    7.3.1 Company profile

    7.3.2 Representative H1N1 Vaccines Product

    7.3.3 H1N1 Vaccines Sales, Revenue, Price and Gross Margin of Novartis

    7.4 GlaxoSmithKline

    7.4.1 Company profile

    7.4.2 Representative H1N1 Vaccines Product

    7.4.3 H1N1 Vaccines Sales, Revenue, Price and Gross Margin of GlaxoSmithKline

    7.5 Serum Institute

    7.5.1 Company profile

    7.5.2 Representative H1N1 Vaccines Product

    7.5.3 H1N1 Vaccines Sales, Revenue, Price and Gross Margin of Serum Institute

    7.6 Sinovac Biotech

    7.6.1 Company profile

    7.6.2 Representative H1N1 Vaccines Product

    7.6.3 H1N1 Vaccines Sales, Revenue, Price and Gross Margin of Sinovac Biotech

    7.7 Zydus Cadila

    7.7.1 Company profile

    7.7.2 Representative H1N1 Vaccines Product

    7.7.3 H1N1 Vaccines Sales, Revenue, Price and Gross Margin of Zydus Cadila

    7.8 BioCSL

    7.8.1 Company profile

    7.8.2 Representative H1N1 Vaccines Product

    7.8.3 H1N1 Vaccines Sales, Revenue, Price and Gross Margin of BioCSL

    7.9 Mitsubishi Tanabe Pharma

    7.9.1 Company profile

    7.9.2 Representative H1N1 Vaccines Product

    7.9.3 H1N1 Vaccines Sales, Revenue, Price and Gross Margin of Mitsubishi Tanabe Pharma

    7.10 Protein Sciences Corporation

    7.10.1 Company profile

    7.10.2 Representative H1N1 Vaccines Product

    7.10.3 H1N1 Vaccines Sales, Revenue, Price and Gross Margin of Protein Sciences Corporation

    7.11 Baxter International

    7.11.1 Company profile

    7.11.2 Representative H1N1 Vaccines Product

    7.11.3 H1N1 Vaccines Sales, Revenue, Price and Gross Margin of Baxter International

    7.12 Sanofi Pastuer

    7.12.1 Company profile

    7.12.2 Representative H1N1 Vaccines Product

    7.12.3 H1N1 Vaccines Sales, Revenue, Price and Gross Margin of Sanofi Pastuer

    7.13 Commonwealth Serum Laboratories (CSL)

    7.13.1 Company profile

    7.13.2 Representative H1N1 Vaccines Product

    7.13.3 H1N1 Vaccines Sales, Revenue, Price and Gross Margin of Commonwealth Serum Laboratories (CSL)

    Chapter 8 Upstream and Downstream Market Analysis of H1N1 Vaccines

    8.1 Industry Chain of H1N1 Vaccines

    8.2 Upstream Market and Representative Companies Analysis

    8.3 Downstream Market and Representative Companies Analysis

    Chapter 9 Cost and Gross Margin Analysis of H1N1 Vaccines

    9.1 Cost Structure Analysis of H1N1 Vaccines

    9.2 Raw Materials Cost Analysis of H1N1 Vaccines

    9.3 Labor Cost Analysis of H1N1 Vaccines

    9.4 Manufacturing Expenses Analysis of H1N1 Vaccines

    Chapter 10 Marketing Status Analysis of H1N1 Vaccines

    10.1 Marketing Channel

    10.1.1 Direct Marketing

    10.1.2 Indirect Marketing

    10.1.3 Marketing Channel Development Trend

    10.2 Market Positioning

    10.2.1 Pricing Strategy

    10.2.2 Brand Strategy

    10.2.3 Target Client

    10.3 Distributors/Traders List

    Chapter 11 Report Conclusion

    Chapter 12 Research Methodology and Reference

    12.1 Methodology/Research Approach

    12.1.1 Research Programs/Design

    12.1.2 Market Size Estimation

    12.1.3 Market Breakdown and Data Triangulation

    12.2 Data Source

    12.2.1 Secondary Sources

    12.2.2 Primary Sources

    12.3 Reference

List Of Tables
in H1N1 Vaccines-EMEA Market Status and Trend Report 2013-2023 [Published by MIReports]

List of Tables


Table Advantage and Disadvantage of Inactivated vaccines

Table Advantage and Disadvantage of Type II

Table Consumption Volume of H1N1 Vaccines in EMEA by Regions 2013-2017

Table Revenue of H1N1 Vaccines in EMEA by Regions 2013-2017

Table Consumption Volume of H1N1 Vaccines in EMEA by Regions 2018-2023

Table Revenue of H1N1 Vaccines in EMEA by Regions 2018-2023

Table Consumption Volume of H1N1 Vaccines in EMEA by Types 2013-2017

Table Revenue of H1N1 Vaccines in EMEA by Types 2013-2017

Table Consumption Volume of H1N1 Vaccines by Types in Europe 2013-2017

Table Consumption Volume of H1N1 Vaccines by Types in Middle East 2013-2017

Table Consumption Volume of H1N1 Vaccines by Types in Africa 2013-2017

Table Consumption Volume Forecast of H1N1 Vaccines in EMEA by Types 2018-2023

Table Revenue Forecast of H1N1 Vaccines in EMEA by Types 2018-2023

Table Demand Volume of H1N1 Vaccines in EMEA by Downstream Industry 2013-2017

Table Demand Volume of H1N1 Vaccines by Downstream Industry in Europe 2013-2017

Table Demand Volume of H1N1 Vaccines by Downstream Industry in Middle East 2013-2017

Table Demand Volume of H1N1 Vaccines by Downstream Industry in Africa 2013-2017

Table Demand Volume Forecast of H1N1 Vaccines in EMEA by Downstream Industry 2018-2023

Table Sales Volume of H1N1 Vaccines in EMEA by Major Players 2013-2017

Table Revenue of H1N1 Vaccines in EMEA by Major Players 2013-2017

Table Headquarters Location and Established Time of H1N1 Vaccines Major Players

Table Employees and Revenue Level of H1N1 Vaccines Major Players

Table Representative H1N1 Vaccines Product One of Medimmune

Table Representative H1N1 Vaccines Product Two of Medimmune

Table H1N1 Vaccines Sales, Revenue, Price and Gross Margin of Medimmune 2013-2017

Table Representative H1N1 Vaccines Product One of AstraZeneca

Table Representative H1N1 Vaccines Product Two of AstraZeneca

Table H1N1 Vaccines Sales, Revenue, Price and Gross Margin of AstraZeneca 2013-2017

Table Representative H1N1 Vaccines Product One of Novartis

Table Representative H1N1 Vaccines Product Two of Novartis

Table H1N1 Vaccines Sales, Revenue, Price and Gross Margin of Novartis 2013-2017

Table Representative H1N1 Vaccines Product One of GlaxoSmithKline

Table Representative H1N1 Vaccines Product Two of GlaxoSmithKline

Table H1N1 Vaccines Sales, Revenue, Price and Gross Margin of GlaxoSmithKline 2013-2017

Table Representative H1N1 Vaccines Product One of Serum Institute

Table Representative H1N1 Vaccines Product Two of Serum Institute

Table H1N1 Vaccines Sales, Revenue, Price and Gross Margin of Serum Institute 2013-2017

Table Representative H1N1 Vaccines Product One of Sinovac Biotech

Table Representative H1N1 Vaccines Product Two of Sinovac Biotech

Table H1N1 Vaccines Sales, Revenue, Price and Gross Margin of Sinovac Biotech 2013-2017

Table Representative H1N1 Vaccines Product One of Zydus Cadila

Table Representative H1N1 Vaccines Product Two of Zydus Cadila

Table H1N1 Vaccines Sales, Revenue, Price and Gross Margin of Zydus Cadila 2013-2017

Table Representative H1N1 Vaccines Product One of BioCSL

Table Representative H1N1 Vaccines Product Two of BioCSL

Table H1N1 Vaccines Sales, Revenue, Price and Gross Margin of BioCSL 2013-2017

Table Representative H1N1 Vaccines Product One of Mitsubishi Tanabe Pharma

Table Representative H1N1 Vaccines Product Two of Mitsubishi Tanabe Pharma

Table H1N1 Vaccines Sales, Revenue, Price and Gross Margin of Mitsubishi Tanabe Pharma 2013-2017

Table Representative H1N1 Vaccines Product One of Protein Sciences Corporation

Table Representative H1N1 Vaccines Product Two of Protein Sciences Corporation

Table H1N1 Vaccines Sales, Revenue, Price and Gross Margin of Protein Sciences Corporation 2013-2017

Table Representative H1N1 Vaccines Product One of Baxter International

Table Representative H1N1 Vaccines Product Two of Baxter International

Table H1N1 Vaccines Sales, Revenue, Price and Gross Margin of Baxter International 2013-2017

Table Representative H1N1 Vaccines Product One of Sanofi Pastuer

Table Representative H1N1 Vaccines Product Two of Sanofi Pastuer

Table H1N1 Vaccines Sales, Revenue, Price and Gross Margin of Sanofi Pastuer 2013-2017

Table Representative H1N1 Vaccines Product One of Commonwealth Serum Laboratories (CSL)

Table Representative H1N1 Vaccines Product Two of Commonwealth Serum Laboratories (CSL)

Table H1N1 Vaccines Sales, Revenue, Price and Gross Margin of Commonwealth Serum Laboratories (CSL) 2013-2017

List Of Figures, Charts and Diagrams
in H1N1 Vaccines-EMEA Market Status and Trend Report 2013-2023 [Published by MIReports]

List of Figures


Figure Representative Commercial Product Picture of H1N1 Vaccines

Figure EMEA Consumption Volume Share of H1N1 Vaccines by Types in 2017

Figure Representative Commercial Product Picture of Inactivated vaccines

Figure Representative Commercial Product Picture of Type II

Figure Demand Volume Share of H1N1 Vaccines by Downstream Industry in 2017

Figure Swine flu Examples of H1N1 Vaccines

Figure Application 2 Examples of H1N1 Vaccines

Figure EMEA H1N1 Vaccines Revenue and Growth Rate 2013-2023

Figure EMEA H1N1 Vaccines Market Size Comparison in 2013, 2017 and 2023

Figure Europe H1N1 Vaccines Revenue and Growth Rate 2013-2023

Figure Middle East H1N1 Vaccines Revenue and Growth Rate 2013-2023

Figure Africa H1N1 Vaccines Revenue and Growth Rate 2013-2023

Figure Consumption Volume and Growth Rate of H1N1 Vaccines in EMEA 2013-2017

Figure Revenue and Growth Rate of H1N1 Vaccines in EMEA 2013-2017

Figure Consumption Volume Share of H1N1 Vaccines in EMEA by Regions 2013-2017

Figure Consumption Volume Share of H1N1 Vaccines in EMEA by Regions in 2013

Figure Consumption Volume Share of H1N1 Vaccines in EMEA by Regions in 2017

Figure Consumption Volume Growth Rate Comparison of H1N1 Vaccines in EMEA by Regions 2013-2017

Figure Revenue Share of H1N1 Vaccines in EMEA by Regions 2013-2017

Figure Revenue Share of H1N1 Vaccines in EMEA by Regions in 2013

Figure Revenue Share of H1N1 Vaccines in EMEA by Regions in 2017

Figure Revenue Growth Rate Comparison of H1N1 Vaccines in EMEA by Regions 2013-2017

Figure Consumption Volume and Growth Rate of H1N1 Vaccines in Europe 2013-2017

Figure Revenue and Growth Rate of H1N1 Vaccines in Europe 2013-2017

Figure Consumption Volume and Growth Rate of H1N1 Vaccines in Middle East 2013-2017

Figure Revenue and Growth Rate of H1N1 Vaccines in Middle East 2013-2017

Figure Consumption Volume and Growth Rate of H1N1 Vaccines in Africa 2013-2017

Figure Revenue and Growth Rate of H1N1 Vaccines in Africa 2013-2017

Figure Consumption Volume and Growth Rate of H1N1 Vaccines in EMEA 2018-2023

Figure Revenue and Growth Rate of H1N1 Vaccines in EMEA 2018-2023

Figure Consumption Volume Share of H1N1 Vaccines in EMEA by Regions in 2023

Figure Revenue Share of H1N1 Vaccines in EMEA by Regions in 2023

Figure Consumption Volume Share of H1N1 Vaccines in EMEA by Types 2013-2017

Figure Consumption Volume Share of H1N1 Vaccines in EMEA by Types in 2013

Figure Consumption Volume Share of H1N1 Vaccines in EMEA by Types in 2017

Figure Consumption Volume Growth Rate Comparison of H1N1 Vaccines in EMEA by Types 2013-2017

Figure Revenue Share of H1N1 Vaccines in EMEA by Types 2013-2017

Figure Revenue Share of H1N1 Vaccines in EMEA by Types in 2013

Figure Revenue Share of H1N1 Vaccines in EMEA by Types in 2017

Figure Revenue Growth Rate Comparison of H1N1 Vaccines in EMEA by Types 2013-2017

Figure 2013 Consumption Volume Share of H1N1 Vaccines by Types in Europe

Figure 2017 Consumption Volume Share of H1N1 Vaccines by Types in Europe

Figure 2013 Consumption Volume Share of H1N1 Vaccines by Types in Middle East

Figure 2017 Consumption Volume Share of H1N1 Vaccines by Types in Middle East

Figure 2013 Consumption Volume Share of H1N1 Vaccines by Types in Africa

Figure 2017 Consumption Volume Share of H1N1 Vaccines by Types in Africa

Figure Consumption Volume Share Forecast of H1N1 Vaccines in EMEA by Types in 2023

Figure Revenue Share Forecast of H1N1 Vaccines in EMEA by Types in 2023

Figure Demand Volume Share of H1N1 Vaccines in EMEA by Downstream Industry 2013-2017

Figure Demand Volume Share of H1N1 Vaccines in EMEA by Downstream Industry in 2013

Figure Demand Volume Share of H1N1 Vaccines in EMEA by Downstream Industry in 2017

Figure Demand Volume Growth Rate Comparison of H1N1 Vaccines in EMEA by Downstream Industry 2013-2017

Figure 2013 Demand Volume Share of H1N1 Vaccines by Downstream Industry in Europe

Figure 2017 Demand Volume Share of H1N1 Vaccines by Downstream Industry in Europe

Figure 2013 Demand Volume Share of H1N1 Vaccines by Downstream Industry in Middle East

Figure 2017 Demand Volume Share of H1N1 Vaccines by Downstream Industry in Middle East

Figure 2013 Demand Volume Share of H1N1 Vaccines by Downstream Industry in Africa

Figure 2017 Demand Volume Share of H1N1 Vaccines by Downstream Industry in Africa

Figure Demand Volume Share Forecast of H1N1 Vaccines in EMEA by Downstream Industry in 2023

Figure Sales Volume Share of H1N1 Vaccines in EMEA by Major Players in 2013

Figure Sales Volume Share of H1N1 Vaccines in EMEA by Major Players in 2017

Figure Revenue Share of H1N1 Vaccines in EMEA by Major Players in 2013

Figure Revenue Share of H1N1 Vaccines in EMEA by Major Players in 2017

Figure H1N1 Vaccines Revenue and EMEA Share of Medimmune 2013-2017

Figure H1N1 Vaccines Revenue and EMEA Share of AstraZeneca 2013-2017

Figure H1N1 Vaccines Revenue and EMEA Share of Novartis 2013-2017

Figure H1N1 Vaccines Revenue and EMEA Share of GlaxoSmithKline 2013-2017

Figure H1N1 Vaccines Revenue and EMEA Share of Serum Institute 2013-2017

Figure H1N1 Vaccines Revenue and EMEA Share of Sinovac Biotech 2013-2017

Figure H1N1 Vaccines Revenue and EMEA Share of Zydus Cadila 2013-2017

Figure H1N1 Vaccines Revenue and EMEA Share of BioCSL 2013-2017

Figure H1N1 Vaccines Revenue and EMEA Share of Mitsubishi Tanabe Pharma 2013-2017

Figure H1N1 Vaccines Revenue and EMEA Share of Protein Sciences Corporation 2013-2017

Figure H1N1 Vaccines Revenue and EMEA Share of Baxter International 2013-2017

Figure H1N1 Vaccines Revenue and EMEA Share of Sanofi Pastuer 2013-2017

Additional Details

Publisher

MIReports

Publisher Information

Headquartered in Haidian District, Beijing, MIReports is a global information consulting company, focusing on market data collection and professional analysis.

Reference

238162 |

Number of Pages

156

Report Format

PDF

MIReports Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 12% today! H1N1 (Swine Influenza) -Epidemiology Forecast to 2025
DelveInsight “H1N1 (Swine Influenza) - Epidemiology Forecast To 2025” provides an overview of the ep...
10 Oct 2017 by Delve Insight USD $2,420 (normally
USD $2,750)
More Info
SAVE 12% today! Influenza A Virus, H1N1 Subtype Infections Global Clinical Trials Review, H2, 2017
Influenza A Virus, H1N1 Subtype Infections Global Clinical Trials Review, H2, 2017SummaryGlobalData'...
30 Aug 2017 by Global Data USD $2,200 (normally
USD $2,500)
More Info
SAVE 12% today! H1N1 infection - Pipeline Insight, 2017
DelveInsight’s, “H1N1 infection-Pipeline Insights, 2017”, report provides comprehensive insights of ...
31 Jul 2017 by Delve Insight USD $1,100 (normally
USD $1,250)
More Info
SAVE 12% today! H1N1 infection - Pipeline Insight, 2017
DelveInsight’s, “H1N1 infection-Pipeline Insights, 2017”, report provides comprehensive insights of ...
31 Jul 2017 by Delve Insight USD $1,100 (normally
USD $1,250)
More Info
SAVE 12% today! H1N1 (Swine Influenza) - Epidemiology Forecast To 2023
DelveInsight “H1N1 (Swine Influenza) - Epidemiology Forecast To 2023” provides an overview of the ep...
31 May 2017 by Delve Insight USD $2,420 (normally
USD $2,750)
More Info
SAVE 12% today! H1N1 (Swine Influenza)- Market Insights, Epidemiology and Market Forecast-2023
Note*: This report requires 5-7 business days to complete.DelveInsight’s H1N1 (Swine Influenza) - Ma...
30 May 2017 by Delve Insight USD $4,356 (normally
USD $4,950)
More Info
SAVE 12% today! Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H1 2017
Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H1 2017SummaryGlobal Markets Direct's ...
31 Mar 2017 by Global Markets Direct USD $1,760 (normally
USD $2,000)
More Info
SAVE 12% today! Influenza A Virus, H1N1 Subtype Infections Global Clinical Trials Review, H2, 2016
Influenza A Virus, H1N1 Subtype Infections Global Clinical Trials Review, H2, 2016SummaryGlobalData'...
30 Sep 2016 by Global Data USD $2,200 (normally
USD $2,500)
More Info
SAVE 12% today! Influenza A Virus, H1N1 Subtype Infections Global Clinical Trials Review, H2, 2016
Influenza A Virus, H1N1 Subtype Infections Global Clinical Trials Review, H2, 2016SummaryGlobalData'...
30 Sep 2016 by Global Data USD $2,200 (normally
USD $2,500)
More Info
SAVE 12% today! H1N1 Vaccine Market- By Vaccine Type (Flu Shot, FluMist), By Type of Brands (Agripal, Fiuarix , Influgen, Influvac, Nasovac, Vaxigrip) & By Geography- Analysis & Forecast (2016- 2021)
H1N1 is an influenza virus with swine origin and the disease caused by this virus is usually recogni...
29 Feb 2016 by USD $4,620 (normally
USD $5,250)
More Info

This report is published by MIReports

Headquartered in Haidian District, Beijing, MIReports is a global information consulting company, focusing on market data collection and professional analysis.

Download Free Report Summary PDF

H1N1 Vaccines-EMEA Market Status and Trend Report 2013-2023 [Published by MIReports] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...